Dabigatran vs Osimertinib

Dabigatran vs Osimertinib: Overview

This comparison examines the pharmacological differences between Dabigatran and Osimertinib.

Mechanism of Action

Dabigatran: Direct thrombin (Factor IIa) inhibitor.

Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

Pharmacokinetics

Half-life: Dabigatran — 12-17 hours; Osimertinib — 48 hours.

Chemical Properties

Molecular Formula: Dabigatran — C25H25N7O3; Osimertinib — C28H33N7O2.

Molecular Weight: Dabigatran — 471.5100 g/mol; Osimertinib — 499.6050 g/mol.

Type: Dabigatran — Small molecule; Osimertinib — Small molecule.